Received: 22 December 2017; Accepted: 1 February 2018; Published: 3 February 2018

Size: px
Start display at page:

Download "Received: 22 December 2017; Accepted: 1 February 2018; Published: 3 February 2018"

Transcription

1 viruses Article A Simple Mechanism Based on Amino Acid Substitutions is not a Critical Determinant of High Mortality of Japanese Encephalitis Virus Infection in Mice Yuki Takamatsu 1,, Leo Uchida 1,, Muhareva Raekiansyah 1, Mark Anthony Luz 1, Kouichi Morita 1,2 and Daisuke Hayasaka 1,2,3, * 1 Department of Virology, Institute of Tropical Medicine, Nagasaki University, Sakamoto, Nagasaki , Japan; yuki.takamatsu@staff.uni-marburg.de (Y.T.); uchidaleo@rakuno.ac.jp (L.U.); m.raekiansyah@gmail.com (M.R.); markanthonyluz@gmail.com (M.A.L.); moritak@nagasaki-u.ac.jp (K.M.) 2 Leading Graduate School Program, Nagasaki University, Nagasaki , Japan 3 Center for Control and Prevention of Infectious Diseases, Nagasaki University, Nagasaki , Japan * Correspondence: hayasaka@nagasaki-u.ac.jp; Tel.: ; Fax: Current Affiliation: Institute of Virology, Philipps University Marburg, Marburg, Germany. Current Affiliation: Laboratory of Zoonotic Diseases, Division of Health and Environmental Science, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu , Japan. Received: 22 December 2017; Accepted: 1 February 2018; Published: 3 February 2018 Abstract: For the development of effective treatment strategies for Japanese encephalitis (JE), it is important to identify the viral factors causing severe disease during JE virus (JEV) infection. In this study, we assessed whether amino acid substitutions are critical factors for higher mortality of JaTH160 compared with JaOArS982 in mice using the technique of infectious cdna clones. We raised the possibility that two amino acids of C 124 and NS3 482 of JaTH160 may contribute to increased mortality in mice. However, simultaneous substitutions of these amino acids did not significantly increase the virulence of JaOArS982, suggesting that high mortality due to JaTH160 viral infection cannot be simply attributed to the specific amino acids. Multiple and complex, but not simple, mechanisms may induce the high mortality of JaTH160 infection in mice. Keywords: Japanese encephalitis virus; pathogenicity; mouse; recombinant; amino acid substitution 1. Introduction Japanese encephalitis (JE) virus (JEV) causes approximately 30,000 to 50,000 cases and 10,000 to 15,000 deaths in Asian countries annually [1,2]. JEV belongs to the family Flaviviridae, genus Flavivirus [3,4], whose genomic RNA encodes three structural (C, prm, and E) and seven nonstructural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins [5]. The clinical symptoms of JE vary from mild to severe disease, including a non-specific febrile illness, meningitis, encephalitis and meningoencephalitis [6,7]. However, the mechanism of severe central nervous system (CNS) disease has not been fully elucidated. To evaluate the disease pathogenesis in JEV infection, mice have been employed as a useful infection model [8 10]. Mouse models of JEV infection have suggested that several viral and host factors affect disease severity during JEV infection. We previously showed that subcutaneous infection with the JaTH160 strain of JEV causes significantly higher mortality and more pronounced virus propagation in the brains of mice compared with those of the JaOArS982 strain [9]. Thus, we have considered that genome-based comparisons between JaTH160 and JaOArS982 strains would provide Viruses 2018, 10, 62; doi: /v

2 Viruses 2018, 10, 62 2 of 10 useful information for identifying the viral factors responsible for the pathogenicity in JEV infection in vivo. Previous studies have demonstrated that amino acid substitutions are major factors affecting the virulence in flavivirus infections. For example, it has been shown that amino acid substitutions in the E protein, such as E 49, E 123, E 138, E 176, E 306, and E 389/390 affect the virulence of flaviviruses in the CNS [11 14], and amino acids, such as C 42,43, prm 15,17, NS2A 23, and NS ,891, contribute to the flavivirus pathogenicity in mice [15 18]. We have also focused on the amino acid substitutions between JaTH160 and JaOArS982 strains to elucidate the pathogenicity in our previous studies. JaTH160, but not JaOArS982, expresses the NS1 protein and that NS1 enhances JEV production in avian cells and embryonated chicken eggs [19]. Previous studies have shown that the NS1 protein plays a role in the enhanced virulence of the JEV SA14 strain in mice [20]. Thus, we have predicted that NS1 protein is a critical factor of the higher pathogenicity of JaTH160 compared with JaOArS982. However, our data suggested that NS1 protein expression in the JaOArS982 strain reduces the mortality in mice, suggesting that the effect of NS1 on pathogenicity in vivo may vary among virus strains [21]. We also identified a unique amino acid of NS2A 113 phenylalanine that affects the efficient propagation of JaTH160 in neuroblastoma Neuro-2a cells, but not extraneural origin cells compared with the JaOArS982 strain [22]. Therefore, we predicted that this NS2A 113 phenylalanine is responsible for the high pathogenicity of JaTH160. However, this amino acid did not affect viral loads in the brain nor survival curves in mice, suggesting that virus propagation in vitro may not reflect the level of virus neurovirulence in vivo [22]. There are 19 amino acid differences between JaTH160 and JaOArS982. Therefore, in the present study, we aimed to identify the amino acids affecting the virulence and to assess whether those amino acid substitutions are critical to determine the high mortality due to JaTH160 infection by a reductionist approach using the infectious cdna clone techniques of JaTH160 and JaOArS982 strains. 2. Materials and Methods 2.1. Ethical Statement The animal experiment protocols were approved by the Animal Care and Use Committee of Nagasaki University (approval number: / December , / August ). The animal experiments were performed in accordance with the recommendations in the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology Viruses and Cells The full-length cdna clones S982-IC and JaTH-IC were developed from the genome sequences of JaOArS982 and JaTH160 strains, respectively, as described previously [19]. Based on the S982-IC and JaTH-IC, recombinant JEV clones were constructed at the unique restriction enzyme sites, and the point mutations were introduced by site-directed mutagenesis as described previously [19]. The plasmids containing the full-length cdna clones were linearized and transcribed into RNA using an SP6 transcription kit (mmessage mmachine SP6 kit, Life Technologies, Carlsbad, CA, USA) [23]. The RNAs were introduced into baby hamster kidney (BHK) cells by electroporation. Infectious viruses were recovered from those cell culture fluids. Virus stocks were stored at 80 C until they were used. Viral titers were determined by plaque-forming assays using BHK cells and were expressed as plaque forming unit (PFU)/mL [24]. BHK cells were maintained in Eagle s Minimal Essential Medium (EMEM) containing 10% fetal calf serum (FCS) and antibiotics.

3 Viruses 2018, 10, 62 3 of Mice C57BL/6j (B6) mice were purchased from Japan SLC, Inc, or Japan CLEA, Inc. Five- to seven-week-old mice were subcutaneously inoculated with 10 4 PFU of JEV diluted in EMEM containing 2% FCS. Mock infected mice were inoculated with supernatant of cultured BHK cells. Mice were weighed daily, and survivals were recorded for 21 days. Viruses 2018, 10, x FOR PEER REVIEW 3 of Statistical Analyses FCS. Mock infected mice were inoculated with supernatant of cultured BHK cells. Mice were weighed The log-rank daily, and (Mantel-Cox) survivals were recorded test wasfor used 21 days. for statistical analysis to assess the significant differences of survival curves between each recombinant virus and S982-infectious clone (IC) virus. A p value of 2.4. Statistical Analyses <0.05 was considered statistically significant. The log-rank (Mantel-Cox) test was used for statistical analysis to assess the significant differences of survival curves between each recombinant virus and S982-infectious clone (IC) virus. 3. Results A p value of <0.05 was considered statistically significant Separate 3. Results Regions of Viral Genome Affect the High Mortality in Mice Amino 3.1. acid Separate differences Regions of Viral between Genome Affect JaOArS982 the High Mortality and JaTH160 in Mice are shown in Figure 1A. S982-IC and JaTH-IC viruses showed 47 and 100% mortality in mice, respectively (Figure 1B). To address Amino acid differences between JaOArS982 and JaTH160 are shown in Figure 1A. S982-IC and the aminojath-ic acids affecting viruses showed the 47 different and 100% levels mortality of virulence in mice, respectively between(figure these1b). viruses, To address wethe applied the reductionist amino approach, acids affecting whichthe introduces different levels JaTH-IC of virulence viral genome between these regions viruses, intowe S982-IC, applied and the assessed those recombinant reductionist viruses approach, bywhich whether introduces mortality JaTH-IC reached viral genome highregions rates, into ideally S982-IC, 100%. and We assessed expected this those recombinant viruses by whether mortality reached high rates, ideally 100%. We expected this approach to narrow down the regions of viral genome stepwise and finally determine the amino acids approach to narrow down the regions of viral genome stepwise and finally determine the amino of JaTH160acids responsible of JaTH160 for responsible the high for mortality the high mortality in mice. in mice. Figure 1. Mortalities of mice infected with recombinant viruses of JaOArS982 and JaTH160 replacing four distinct regions of the viral genome. (A) schematic representation of 19 amino acid differences of

4 Viruses 2018, 10, 62 4 of 10 Viruses 2018, 10, x FOR PEER REVIEW 4 of 10 recombinant S982-IC and JaTH-IC viruses derived from JaOArS982 and JaTH160, respectively. Numbers Figure 1. Mortalities of mice infected with recombinant viruses of JaOArS982 and JaTH160 replacing indicate the position of amino acid in each responsible protein, respectively. (B) Survival curves and four distinct regions of the viral genome. mortality rates of mice infected with 10 4 (A) schematic representation of 19 amino acid differences of recombinant S982-IC and JaTH-IC viruses pfuderived of S982-IC from (n JaOArS982 = 15) and and JaTH-IC JaTH160, (n = respectively. 15) for 21 days. Opened Numbers and closed indicate diamonds the position indicate of amino S982-IC acid in and each JaTH-IC, responsible respectively. protein, respectively. The log-rank (B) Survival (Mantel-Cox) test was curves usedand for mortality statistical rates analysis of mice infected to assess with significant 10 4 pfu of differences S982-IC (n = 15) of and survival JaTH-IC curves. (n = 15) Afor p value 21 of <0.05 was days. considered Opened and statistically closed diamonds significant. indicate S982-IC (C) Survival and JaTH-IC, curvesrespectively. and mortality The log-rank rates of (Mantel- mice infected with 10 Cox) 4 pfu test of was S-J1 used (n for = 10), statistical S-J2 (n analysis = 10), to S-J3 assess (n significant = 9) and differences S-J4 (n = 9) of viruses survival curves. based on A p S982-IC, value in of <0.05 was considered statistically significant. (C) Survival curves and mortality rates of mice which genome regions 1 (5 untranslated region (UTR)-NS1 323 ), 2 (NS NS3 35 ), 3 (NS3 36 -NS5 567 ), infected with 10 and 4 (NS UTR) 4 pfu of S-J1 (n = 10), S-J2 (n = 10), S-J3 (n = 9) and S-J4 (n = 9) viruses based on S982- were replaced with those of S982-IC, respectively. Closed triangles indicate IC, in which genome regions 1 (5 untranslated region (UTR)-NS1323), 2 (NS1324-NS335), 3 (NS336- recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids NS5567), and 4 (NS UTR) were replaced with those of S982-IC, respectively. Closed triangles derived indicate from JaTH-IC. recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC. We first constructed four recombinant viruses (S-J1, S-J2, S-J3 and S-J4) based on S982-IC by introducing We four first regions constructed of JaTH-IC four recombinant (Figure 1C). viruses Mortalities (S-J1, S-J2, of S-J1-, S-J3 and S-J2-, S-J4) S-J3-, based andon S-J4-infected S982-IC by mice were 80, introducing 40, 50, and four 67%, regions respectively, of JaTH-IC and (Figure S-J11C). virus Mortalities infection of was S-J1-, found S-J2-, S-J3-, to cause and S-J4-infected higher mortality mice were 80, 40, 50, and 67%, respectively, and S-J1 virus infection was found to cause higher than others (Figure 1C). mortality than others (Figure 1C). We next constructed recombinant viruses of J-S1, J-S2, J-S3, and J-S4 based on JaTH-IC by replacing We next constructed recombinant viruses of J-S1, J-S2, J-S3, and J-S4 based on JaTH-IC by the four replacing regions the of four S982-IC regions (Figure of S982-IC 2A). (Figure Infections 2A). Infections with J-S2with andj-s2 J-S4 and viruses J-S4 viruses caused caused and 91% mortality and 91% in mice, mortality respectively in mice, respectively (Figure 2A). (Figure On the 2A). other On the hand, other infections hand, infections with with J-S1 J-S1 and and J-S3 J-S3 viruses resulted viruses in 55resulted and 73% in 55 mortality and 73% in mortality mice, respectively in mice, respectively (Figure (Figure 2A). 2A). Figure 2. Mortalities of mice infected with recombinant viruses based on S982-IC and JaTH-IC. (A) Survival curves and mortality rates of mice infected with 10 4 pfu of J-S1 (n = 11), J-S2 (n = 13), J-S3

5 Viruses 2018, 10, 62 5 of 10 (n = Viruses 11), 2018, and10, J-S4 x FOR (n PEER = 11) REVIEW viruses based on JaTH-IC, in which genome regions 1, 2, 3, and5 4of were 10 replaced with those of S982-IC, respectively. (B) Survival curves and mortality rates of mice infected with 10 4 Figure 2. Mortalities of mice infected with recombinant viruses based on S982-IC and JaTH-IC. (A) pfu of S-J13 (n = 10) and S-J24 (n = 10), whose genome regions 1 and 3, or regions 2 and 4, Survival curves and mortality rates of mice infected with 10 4 pfu of J-S1 (n = 11), J-S2 (n = 13), J-S3 (n were of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate = 11), and J-S4 (n = 11) viruses based on JaTH-IC, in which genome regions 1, 2, 3, and 4 were replaced the positions with those andof numbers S982-IC, respectively. of amino acids (B) Survival derivedcurves fromand JaTH-IC. mortality rates of mice infected with 10 4 pfu of S-J13 (n = 10) and S-J24 (n = 10), whose genome regions 1 and 3, or regions 2 and 4, were of From these JaTH-IC. results, Closed we triangles postulated indicate recombinant that a combination viruses. The of black distinct inverted regions triangles of indicate 5 UTR-NS1 the 323 and NS3 36 -NS5 positions 567 mayand contribute numbers of amino to theacids high derived mortality from JaTH-IC. due to JaTH-IC virus infection. Thus, we examined the mortality due to S-J13 virus infection in mice, whose regions of 5 UTR-NS1 323 and From these results, we postulated that a combination of distinct regions of 5 UTR-NS1323 and NS3 36 -NS5 NS336-NS weremay of JaTH-IC, contribute and to the other high mortality regionsdue were to JaTH-IC of S982-IC virus (Figure infection. 2B). Thus, The we mortality examined rate of S-J13 virus-infected the mortality due mice to S-J13 was 80%, virus infection although in the mice, survival whose regions curveof was 5 UTR-NS1323 not significantly and NS336-NS5567 different from that of S982-IC were of JaTH-IC, virus (Figure and other 2B). regions were of S982-IC (Figure 2B). The mortality rate of S-J13 virusinfected mice it iswas controversial 80%, although asthe tosurvival whether curve thewas virulence not significantly of S-J13 different virus from is significantly that of S982- higher Although IC virus (Figure 2B). than that of S982-IC virus, we further attempted to focus narrowly on the site of 5 UTR-NS1 323 and Although it is controversial as to whether the virulence of S-J13 virus is significantly higher than NS3 36 -NS5 that 567 of S982-IC. Thus, virus, we further we further constructed attempted recombinant to focus narrowly viruses on the by site dividing of the 5 UTR-NS1 323 and 5 UTR-NS1323 and NS336- NS3 36 -NS5 NS Thus, regions we into further three constructed and tworecombinant regions, respectively. viruses by dividing the 5 UTR-NS1323 and NS336- Recombinant NS5567 regions viruses into three ofand S-J13a two regions, and S-J13b respectively. were constructed as containing NS3 36 -NS4B 110 and NS4B 111 -NS5 Recombinant 567 of JaTH-IC viruses based of S-J13a on S-J1, and respectively S-J13b were constructed (Figure 3A). as containing NS336-NS4B110 Mortality of S-J13a virus-infected and NS4B111-NS5567 of JaTH-IC based on S-J1, respectively (Figure 3A). Mortality of S-J13a virus-infected mice was 100%, whereas that of S-J13b infected mice was 20% (Figure 3A). On the other hand, following mice was 100%, whereas that of S-J13b infected mice was 20% (Figure 3A). On the other hand, infections with recombinant viruses of S-J1a3, S-J1b3, and S-J1c3 containing 5 UTR-M, M 153 -E 303, following infections with recombinant viruses of S-J1a3, S-J1b3, and S-J1c3 containing 5 UTR-M152, or E 304 -NS1 M153-E303, 323 of or JaTH-IC based on S-J3, respectively, mortalities were 80, 70, and 60%, respectively, E304-NS1323 of JaTH-IC based on S-J3, respectively, mortalities were 80, 70, and 60%, and S-J1a3 respectively, infectionand showed S-J1a3 infection a highershowed mortality a higher (Figure mortality 3B). (Figure 3B). Figure 3. Mortalities of mice infected with S-J13-based recombinant viruses. (A) Survival curves and mortality rates of mice infected with 10 4 pfu of S-J13a (n = 10) and S-J13b (n = 5) and 3b (NS4B 111 -NS5 567 )

6 Viruses 2018, 10, 62 6 of 10 Viruses 2018, 10, x FOR PEER REVIEW 6 of 10 Figure 3. Mortalities of mice infected with S-J13-based recombinant viruses. (A) Survival curves and mortality rates of mice infected with 10 were replaced with those of JaTH-IC. (B) 4 pfu of S-J13a (n = 10) and S-J13b (n = 5) based on S-J13, in Survival curves and mortality rates of mice infected with 10 4 which regions 3a (NS336-NS4B110) and 3b (NS4B111-NS5567) were replaced with those of JaTH-IC. (B) pfu of S-J1a3 (n = 10), S-J1b3 (n = 10), and S-J1c3 (n = 5) based on S-J13, in which regions 1a (5 UTR-M 152 ), Survival curves and mortality rates of mice infected with 10 1b (M 153 -E 303 ), and 1c (E 304 -NS1 323 ) were replaced with those 4 pfu of S-J1a3 (n = 10), S-J1b3 (n = 10), and of JaTH-IC. Closed triangles indicate S-J1c3 (n = 5) based on S-J13, in which regions 1a (5 UTR-M152), 1b (M153-E303), and 1c (E304-NS1323) were recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids replaced with those of JaTH-IC. Closed triangles indicate recombinant viruses. The black inverted derived from JaTH-IC. triangles indicate the positions and numbers of amino acids derived from JaTH-IC. From From these these results, results, we we further further focused focused on on the the amino amino acids acids in in the the 5 UTR-M 152 and NS3 36 -NS4B 5 UTR-M152 and NS336-NS4B regions, regions, where where viral viral genome genome sequences of of JaTH160 may induce high highmortality mortalityin inmice. mice Amino Amino Acids Acids C 124 and NS3 482 of JaTH160 May Affect the High Mortality in Mice C124 and NS3482 of JaTH160 May Affect the High Mortality in Mice To To focus focus on on amino amino acid acid substitutions, we next constructed recombinant recombinant viruses viruses based based on on S-J3 S-J3 and and S-J1 S-J1 by by inserting a point mutation mutation that that substituted substituted the amino the amino acids in acids each in5 UTR-M152 each 5 UTR-M and NS and NS3 NS4B NS4B region. 110 region. There There are are two two amino acid differences in the 5 UTR-M region between S982-IC and and JaTH-IC. JaTH-IC. We We constructed S-JC S-JC1243a and S-JM1403a as containing a point mutation of the position C124 C 124 and andm140 M 140 based on on S-J3, respectively (Figure 4A). After infections with these viruses, mortalities of of mice mice were were and and 80%, 80%, respectively (Figure 4A). Figure 4. Cont.

7 Viruses 2018, 10, 62 7 of 10 Viruses 2018, 10, x FOR PEER REVIEW 7 of 10 Figure 4. Mortalities Figure 4. of Mortalities mice infected of mice withinfected recombinant with viruses recombinant inserting viruses pointinserting mutations. point (A) mutations. Survival (A) curves andsurvival mortality curves ratesand of mice mortality infected rates with of mice 10 4 infected pfu of S-JC with a pfu (n of = 10) S-JC1243a and S-JM (n = 10) 140 3a and (n S-JM1403a = 10) (n viruses based = 10) onviruses S982-IC based containing S982-IC genome containing region genome 3a of JaTH-IC, region 3a in of which JaTH-IC, amino which acidsamino C acids C and and M140 M were replaced with those of JaTH-IC, respectively. (B) Survival curves and mortality rates 140 were replaced with those of JaTH-IC, respectively. (B) Survival curves and mortality rates of of mice infected with 10 4 pfu of S-J1aNS3323 (n = 5), S-J1aNS3337 (n = 8), S-J1aNS3482 (n = 10), S-J1aNS3562 mice infected with 10 4 pfu of S-J1aNS3 323 (n = 5), S-J1aNS3 337 (n = 8), S-J1aNS3 482 (n = 10), S-J1aNS3 562 (n = 5), S-J1aNS4A3 (n = 10), and S-J1aNS4B18 (n = 5), S-J1aNS4A (n = 5) viruses based on S982-IC containing genome 3 (n = 10), and S-J1aNS4B 18 (n = 5) viruses based on S982-IC containing genome region 1a of JaTH-IC, in which amino acids NS3323, NS3337, NS3482, NS3562, NS4A3, and NS4B18 region 1a of JaTH-IC, in which amino acids NS3 were 323, NS3 337, NS3 482, NS3 562, NS4A 3, and NS4B 18 were replaced with those of JaTH-IC, respectively. (C) Survival curves and mortality rates of mice infected replaced with those of JaTH-IC, respectively. (C) Survival curves and mortality rates of mice infected with 10 4 pfu of S-J C124NS3482 (n = 10) virus based on S982-IC, whose amino acid positions of C124 and with 10 4 pfu of S-J C 124 NS3 482 (n = 10) virus based on S982-IC, whose amino acid positions of C 124 NS3482 were of JaTH160-IC. Closed triangles indicate recombinant viruses. The black inverted and NS3 482 were of JaTH160-IC. Closed triangles indicate recombinant viruses. The black inverted triangles indicate the positions and numbers of amino acids derived from JaTH-IC. triangles indicate the positions and numbers of amino acids derived from JaTH-IC. On the other hand, there are six amino acid differences in the NS336-NS4B110 region between On the S982-IC other hand, JaTH-IC there are (Figure six amino 1A). Thus, acid differences we constructed in therecombinant NS3 36 -NS4Bviruses 110 region of S-J1aNS3323, between S- S982-IC and J1aNS3337, JaTH-IC S-J1aNS3482, (Figure S-J1aNS3562, 1A). Thus, S-J1aNS4A3, we constructed and S-J1aNS4B18, recombinant to contain viruseseach of S-J1aNS3 point mutation 323, of S-J1aNS3 337 the, S-J1aNS3 position NS3323, 482, S-J1aNS3 NS3337, 562 NS3482,, S-J1aNS4A NS3562, NS4A3, 3, and S-J1aNS4B and NS4B18 18 of, to JaTH160 containbased each on point S-J1a, mutation respectively of the position (Figure NS3 4B). 323 Following, NS3 337, infections NS3 482, NS3 with 562 these, NS4A viruses, 3, and mortalities NS4B 18 of ofinfected JaTH160 mice based were on 20, S-J1a, 63, 90, 60, respectively 70, (Figure and 40%, 4B). respectively Following(Figure infections 4B). with these viruses, mortalities of infected mice were 20, 63, 90, 60, 70, and These 40%, results respectively suggested (Figure that the 4B). amino acids C124 and NS3482 of JaTH-IC may contribute to the Thesehigh results mortality suggested of JaTH-IC that the infection, amino and acids provide C 124 and the NS3 possibility 482 of JaTH-IC that a combination may contribute of amino to the acids of C124 and NS3482 high mortality of JaTH-ICof infection, JaTH160 is and crucial provide for the thecause possibility of high that mortality a combination mice. of amino acids of C 124 and NS3 482 of JaTH160 is crucial for the cause of high mortality in mice Simultaneous Substitutions of C124 and NS3482 are Not Enough to Cause High Mortality 3.3. Simultaneous We Substitutions predicted that of Csimultaneous 124 and NS3 482 substitutions are Not Enough of C124 to Cause and NS3482 High amino Mortality acids into S982-IC can increase mortality in mice. Therefore, to determine whether amino acids C124 and NS3482 We predicted that simultaneous substitutions of C of JaTH and NS3 482 amino acids into S982-IC can are responsible for the high mortality in mice, we inserted point mutations as containing C124 and increase mortality in mice. Therefore, to determine whether amino acids C 124 and NS3 482 of JaTH160 NS3482 of JaTH160 based on S982-IC (S-JC124NS3482) and examined the mortality in virus-infected mice are responsible for the high mortality in mice, we inserted point mutations as containing C 124 and (Figure 4C). However, this virus infection resulted in 20% mortality in mice (Figure 4C). NS3 482 of JaTH160 based on S982-IC (S-JC 124 NS3 482 ) and examined the mortality in virus-infected These results indicated that a combination of amino acids C124 and NS3482 of JaTH160 is not a mice (Figure 4C). However, this virus infection resulted in 20% mortality in mice (Figure 4C). critical factor of the higher mortality of JaTH160 compared with JaOArS982. These results indicated that a combination of amino acids C 124 and NS3 482 of JaTH160 is not a critical factor 4. Discussion of the higher mortality of JaTH160 compared with JaOArS Discussion In this study, to assess whether amino acid differences were crucial determinants for the different mortalities between JaTH160 and JaOArS982 infections in vivo, we attempted to specify the In this amino study, acids to assess responsible whether for amino the high acid mortality differences in mice were by crucial substituting determinants the amino for acids the different of JaOArS982 mortalities to between JaTH160. JaTH160 Based on and the stepwise JaOArS982 approach infections to narrow in vivo, down we attempted the genome toregion specify responsible the amino for the acids responsible high mortality for the of high JEV using mortality recombinant miceviruses by substituting derived from theinfectious amino acids cdna of clones, JaOArS982 we archived to JaTH160. Based two amino on the acid stepwise candidates approach of C124 to and narrow NS3482 down that likely the genome contribute region to the responsible increased mortality for the high in mice. mortality However, of JEV using simultaneous recombinant substitutions viruses derived of these from amino infectious acids based cdna on the clones, S982-IC wedid archived not result two in high amino acid mortality candidates like of JaTH-IC C 124 and virus NS3infection 482 that likely in mice. contribute From these to the observations, increased mortality we suggest in mice. that high However, mortality simultaneous due to substitutions JaTH160 virus of these infection amino cannot acids be based attributed on theto S982-IC a simple did mechanism not resultderived in highfrom mortality like specific JaTH-IC amino virus acids infection of JaTH160, in mice. and From that multiple these observations, and complex we mechanisms suggest that contribute high mortality to the high due to JaTH160 virus infection cannot be attributed to a simple mechanism derived from specific amino acids of JaTH160, and that multiple and complex mechanisms contribute to the high mortality

8 Viruses 2018, 10, 62 8 of 10 of JaTH160 virus infection in mice. We propose that a more sophisticated approach is required to elucidate the viral factors that determine the high virulence of JaTH160 in mice. S-JC 124 3a and S-J1aNS3 482 viruses induced high mortality in mice. However, the mechanism of the pathogenicity may be different between S-JC 124 3a and S-J1aNS3 482 viruses. In the case of the S-JC 124 3a virus, the combination of C 124 and the other amino acids or nucleotide sequences in the region of NS3 36 -NS4B 110 may be important for its pathogenicity. Moreover, the other amino acids located at close regions or separated regions could influence the C 124 -mediated viral pathogenicity. This theory is also applicable for S-J1aNS3 482 infection. It is predicted that such substitutions of amino acids and nucleotides may compensate for the function inducing the high mortality of each virus. However, it is likely to be too complex to determine such viral genome factors. A simple reductionist approach is unlikely to be the practical method of obtaining such data. We previously showed that JaTH160-infected mice developed severe infections of the CNS [9]. On the other hand, JaOArS982-infected mice exhibited varying degrees of encephalitis and different prognoses. We therefore proposed that fatal outcomes are attributable both to immunopathological changes and massive CNS infection [9]. However, it remains unclear whether severe CNS infection of JaTH160 is a direct cause of high mortality in mice or a result of a severe disease course including a specific immune response. In addition, our previous studies of JEV infection have shown that the mortality is not simply determined by neuroinvasiveness, because viral infections in the brains of surviving mice, that did not show apparent clinical signs, were similar levels of viral loads to those of dying mice [9]. These observations raise the possibility that different pathogenicity between JaOArS982 and JaTH160 infections may primarily be attributed to the peripherally induced host responses. Thus, both virus replication itself and host immune response induced by the virus infection should be focused on determining the viral factors for the fatal infection. We also previously showed the increase of tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interleukin (IL)-2, and IL-10 in the brain, and the decrease of TNF-α in the spleen in JaTH160 infected-mice [9]. From these observations we suggest that the varied disease symptoms in JE cases are primarily attributed to the immune response in individuals, and secondary viral factors contribute to the induction of such immune responses. Thus, to elucidate the mechanism of severe disease course based on the viral factors is still a priority in the development of effective treatment strategies for JE. Acknowledgments: This work was supported by JSPS KAKENHI Grant Numbers JP16H05174, JP , JP17H04661, JP15K15126, JP , and JP , and from the Japan Society for the Promotion of Science, Health and Labor Sciences Research Grant on Emerging and Re-emerging Infectious Diseases from the Japanese Ministry of Health, Labor and Welfare, Research on International Cooperation in Medical Science (Japan-US Cooperative Program), Health and Labor Sciences Research Grants, the Cooperative Research Grant(s) of NEKKEN, 2014, and the Japan Initiative for Global Research Network on Infectious Diseases. Author Contributions: Yuki Takamatsu, and Daisuke Hayasaka conceived and designed the experiments; Yuki Takamatsu, Leo Uchida., Muhareva Raekiansyah, and Daisuke Hayasaka performed the experiments; Yuki Takamatsu and Daisuke Hayasaka analyzed the data; Yuki Takamatsu, Mark Anthony Luz, Kouichi Morita and Daisuke Hayasaka wrote the paper. Conflicts of Interest: The authors declare no conflict of interest. References 1. Ghosh, D.; Basu, A. Japanese encephalitis A pathological and clinical perspective. PLoS Negl. Trop. Dis. 2009, 3, e437. [CrossRef] 2. Solomon, T. Flavivirus encephalitis. N. Engl. J. Med. 2004, 351, [CrossRef] 3. Westaway, E.G.; Brinton, M.A.; Gaidamovich, S.; Horzinek, M.C.; Igarashi, A.; Kaariainen, L.; Lvov, D.K.; Porterfield, J.S.; Russell, P.K.; Trent, D.W. Flaviviridae. Intervirology 1985, 24, [CrossRef] 4. Gubler, D.J.; Kuno, G.; Markoff, L. Field's Virology, 5th ed.; Wolters Kluwer Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007; pp Sumiyoshi, H.; Hoke, C.H.; Trent, D.W. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cdna templates. J. Virol. 1992, 66,

9 Viruses 2018, 10, 62 9 of Tsai, T.F. New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, October Vaccine 2000, 18 (Suppl. 2), [CrossRef] 7. Misra, U.K.; Kalita, J. Overview: Japanese encephalitis. Prog. Neurobiol. 2010, 91, [CrossRef] 8. Aoki, K.; Shimada, S.; Simantini, D.S.; Tun, M.M.; Buerano, C.C.; Morita, K.; Hayasaka, D. Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection. Virol. J. 2014, 11, 105. [CrossRef] 9. Hayasaka, D.; Shirai, K.; Aoki, K.; Nagata, N.; Simantini, D.S.; Kitaura, K.; Takamatsu, Y.; Gould, E.; Suzuki, R.; Morita, K. TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection. PLoS ONE 2013, 8, e [CrossRef] 10. Fujii, Y.; Kitaura, K.; Nakamichi, K.; Takasaki, T.; Suzuki, R.; Kurane, I. Accumulation of T-cells with selected T-cell receptors in the brains of Japanese encephalitis virus-infected mice. Jpn. J. Infect. Dis. 2008, 61, Lee, E.; Hall, R.A.; Lobigs, M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and west nile viruses. J. Virol. 2004, 78, [CrossRef] 12. Ni, H.; Burns, N.J.; Chang, G.J.; Zhang, M.J.; Wills, M.R.; Trent, D.W.; Sanders, P.G.; Barrett, A.D. Comparison of nucleotide and deduced amino acid sequence of the 5 non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J. Gen. Virol. 1994, 75 Pt 6, [CrossRef] 13. Tajima, S.; Nerome, R.; Nukui, Y.; Kato, F.; Takasaki, T.; Kurane, I. A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 2010, 396, [CrossRef] 14. Ni, H.; Chang, G.J.; Xie, H.; Trent, D.W.; Barrett, A.D. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J. Gen. Virol 1995, 76 Pt 2, [CrossRef] 15. Mori, Y.; Okabayashi, T.; Yamashita, T.; Zhao, Z.; Wakita, T.; Yasui, K.; Hasebe, F.; Tadano, M.; Konishi, E.; Moriishi, K.; et al. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J. Virol. 2005, 79, [CrossRef] 16. Kim, J.M.; Yun, S.I.; Song, B.H.; Hahn, Y.S.; Lee, C.H.; Oh, H.W.; Lee, Y.M. A single N-linked glycosylation site in the Japanese encephalitis virus prm protein is critical for cell type-specific prm protein biogenesis, virus particle release, and pathogenicity in mice. J. Virol. 2008, 82, [CrossRef] 17. Melian, E.B.; Hinzman, E.; Nagasaki, T.; Firth, A.E.; Wills, N.M.; Nouwens, A.S.; Blitvich, B.J.; Leung, J.; Funk, A.; Atkins, J.F.; et al. NS1 of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J. Virol. 2010, 84, [CrossRef] 18. Yoshii, K.; Sunden, Y.; Yokozawa, K.; Igarashi, M.; Kariwa, H.; Holbrook, M.R.; Takashima, I. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice. J. Virol. 2014, 88, [CrossRef] 19. Takamatsu, Y.; Okamoto, K.; Dinh, D.T.; Yu, F.; Hayasaka, D.; Uchida, L.; Nabeshima, T.; Buerano, C.C.; Morita, K. NS1 protein expression facilitates production of Japanese encephalitis virus in avian cells and embryonated chicken eggs. J. Gen. Virol. 2014, 95, [CrossRef] 20. Ye, Q.; Li, X.F.; Zhao, H.; Li, S.H.; Deng, Y.Q.; Cao, R.Y.; Song, K.Y.; Wang, H.J.; Hua, R.H.; Yu, Y.X.; et al. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA ) ablates NS1 formation and contributes to attenuation. J. Gen. Virol. 2012, 93, [CrossRef] 21. Takamatsu, Y.; Raekiansyah, M.; Morita, K.; Hayasaka, D. NS1 protein expression in the JaOArS982 strain of Japanese encephalitis virus does not enhance virulence in mice. Trop. Med. Health 2015, 43, [CrossRef] 22. Takamatsu, Y.; Morita, K.; Hayasaka, D. A single amino acid substitution in the NS2A protein of Japanese encephalitis virus affects virus propagation in vitro but not in vivo. J. Virol. 2015, 89, [CrossRef]

10 Viruses 2018, 10, of Hayasaka, D.; Gritsun, T.S.; Yoshii, K.; Ueki, T.; Goto, A.; Mizutani, T.; Kariwa, H.; Iwasaki, T.; Gould, E.A.; Takashima, I. Amino acid changes responsible for attenuation of virus neurovirulence in an infectious cdna clone of the oshima strain of tick-borne encephalitis virus. J. Gen. Virol. 2004, 85, [CrossRef] 24. Hayasaka, D.; Nagata, N.; Fujii, Y.; Hasegawa, H.; Sata, T.; Suzuki, R.; Gould, E.A.; Takashima, I.; Koike, S. Mortality following peripheral infection with tick-borne encephalitis virus results from a combination of central nervous system pathology, systemic inflammatory and stress responses. Virology 2009, 390, [CrossRef] 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (

NS1 Protein Expression in the JaOArS982 Strain of Japanese Encephalitis Virus Does Not Enhance Virulence in Mice

NS1 Protein Expression in the JaOArS982 Strain of Japanese Encephalitis Virus Does Not Enhance Virulence in Mice Tropical Medicine and Health Vol. 43 No.4, 2015, 233 237 doi: 10.2149/tmh.2015-27 Copyright 2015 by The Japanese Society of Tropical Medicine 233 Short Communications NS1 Protein Expression in the JaOArS982

More information

Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection

Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection Aoki et al. Virology Journal 214, 11:15 http://www.virologyj.com/content/11/1/15 RESEARCH Open Access Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese

More information

Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus in human neuroblastoma and glioblastoma cells

Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus in human neuroblastoma and glioblastoma cells Journal of General Virology (),, DOI./vir.. Short Communication Delayed IFN response differentiates replication of West Nile virus and Japanese encephalitis virus in human neuroblastoma and glioblastoma

More information

I.persulcatus BHK. Ixodidae 30% C-1 A-1 Sofjin KH TBE. cdna

I.persulcatus BHK. Ixodidae 30% C-1 A-1 Sofjin KH TBE. cdna 55 pp.35 44 2005 1.,,,, BHK 1 cdna 1 Ns5 2 1. Ixodidae 30% 2 16 1993 17 19 10,000 TBE cdna 060-0818 18 9 TEL 011-706-5211 FAX 011-706-5211 E-mail takasima@vetmed.hokudai.ac.jp 2. 1998 550 5 7 E- 4, 7,

More information

NOTES. The Naturally Attenuated Kunjin Strain of West Nile Virus Shows Enhanced Sensitivity to the Host Type I Interferon Response

NOTES. The Naturally Attenuated Kunjin Strain of West Nile Virus Shows Enhanced Sensitivity to the Host Type I Interferon Response JOURNAL OF VIROLOGY, June 2011, p. 5664 5668 Vol. 85, No. 11 0022-538X/11/$12.00 doi:10.1128/jvi.00232-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. NOTES The Naturally Attenuated

More information

熱帯医学 Tropical medicine 33(1,2). p15

熱帯医学 Tropical medicine 33(1,2). p15 NAOSITE: Nagasaki University's Ac Title Author(s) Comparative Nucleotide and Amino Ac Encephalitis Virus Strains Isolated Tanaka, Mariko; Aira, Yoshikazu; Ig Citation 熱帯医学 Tropical medicine 33(1,2). p15

More information

Development and Application of a Novel Attenuated Live Japanese Encephalitis Vaccine SA

Development and Application of a Novel Attenuated Live Japanese Encephalitis Vaccine SA Development and Application of a Novel Attenuated Live Japanese Encephalitis Vaccine SA14-14-2 Yu Yongxin (National Institute for the Control of Pharmaceutical and Biological Products, Beijing 100050,

More information

The present and future of veterinary vaccines for Japanese encephalitis in Korea

The present and future of veterinary vaccines for Japanese encephalitis in Korea Review article CLINICAL EXPERIMENTAL VACCINE RESEARCH The present and future of veterinary vaccines for Japanese encephalitis in Korea Clin Exp Vaccine Res 2015;4:130-136 pissn 2287-3651 eissn 2287-366X

More information

Envelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid

Envelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid Virus Antib(tdies Your Expertise, Our Antibodies, Accelerated Discovery. Envelope e_---------:------, Envelope glycoproteins e_-------1~ Single-stranded RNA ----, Nucleocapsid First identified in 1989,

More information

Flaviviruses New Challenges, New Vaccines

Flaviviruses New Challenges, New Vaccines Flaviviruses New Challenges, New Vaccines Christian W. Mandl Institute of Virology Medical University of Vienna, AUSTRIA Family Flaviviridae Genus Hepacivirus Genus Pestivirus Genus Flavivirus (>70 members)

More information

Substitution or deletion mutations between nt 54 and 70 in the 59 non-coding region of dengue type 2 virus produce variable effects on virus viability

Substitution or deletion mutations between nt 54 and 70 in the 59 non-coding region of dengue type 2 virus produce variable effects on virus viability Journal of General Virology (2007), 88, 1748 1752 DOI 10.1099/vir.0.82455-0 Short Communication Correspondence Vijittra Leardkamolkarn scvlk@mahidol.ac.th Substitution or deletion mutations between nt

More information

Title. CitationArchives of Virology, 156(11): Issue Date Doc URL. Rights. Type. Additional There Information.

Title. CitationArchives of Virology, 156(11): Issue Date Doc URL. Rights. Type. Additional There Information. Title Construction of a replicon and an infectious cdna cl encephalitis virus Author(s)Takano, Ayako; Yoshii, Kentaro; Omori-Urabe, Yuki; Y CitationArchives of Virology, 156(11): 1931-1941 Issue Date 2011-11

More information

provided the original work is prope

provided the original work is prope NAOSITE: Nagasaki University's Ac Title Author(s) Persistence of Neutralizing Antibod Years from Infection in Nagasaki Ngwe Tun, Mya Myat; Muta, Yoshihito Citation BioResearch Open Access, 5(1), pp.1 Issue

More information

Joseph E. Blaney, Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead

Joseph E. Blaney, Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead JOURNAL OF VIROLOGY, May 2005, p. 5516 5528 Vol. 79, No. 9 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.9.5516 5528.2005 Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a

More information

What is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection?

What is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection? What is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection? Alan D.T. Barrett Department of Pathology and Sealy Center for Vaccine

More information

Pre-clinical Development of a Dengue Vaccine. Jeremy Brett Sanofi Pasteur, Singapore

Pre-clinical Development of a Dengue Vaccine. Jeremy Brett Sanofi Pasteur, Singapore Pre-clinical Development of a Dengue Vaccine Jeremy Brett Sanofi Pasteur, Singapore Dengue Vaccine B Guy 1 Talk flow Introduction: What are the challenges of dengue vaccine development? The Virus The host

More information

BRIEF COMMUNICATION ANTIGENIC ANALYSIS OF JAPANESE ENCEPHALITIS VIRUS ISOLATED IN HOKKAIDO WITH MONOCLONAL ANTIBODIES

BRIEF COMMUNICATION ANTIGENIC ANALYSIS OF JAPANESE ENCEPHALITIS VIRUS ISOLATED IN HOKKAIDO WITH MONOCLONAL ANTIBODIES Title ANTIGENIC ANALYSIS OF JAPANESE ENCEPHALITIS VIRUS IS MONOCLONAL ANTIBODIES Author(s)OCHIAI, Kenichi; TAKASHIMA, Ikuo; HASHIMOTO, Nobuo CitationJapanese Journal of Veterinary Research, 37(1): 21-2

More information

Bioinformation by Biomedical Informatics Publishing Group

Bioinformation by Biomedical Informatics Publishing Group Predicted RNA secondary structures for the conserved regions in dengue virus Pallavi Somvanshi*, Prahlad Kishore Seth Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow 226021, Uttar Pradesh,

More information

A. Study Purpose and Rationale

A. Study Purpose and Rationale IRB Proposal/CRC Rotation Sabrina J Gard, MD MPH Internal Medicine, PGY 1 5 May 2014 A. Study Purpose and Rationale Dengue is the most prevalent arthropod-transmitted virus, with conservative estimates

More information

West Nile Virus. By Frank Riusech

West Nile Virus. By Frank Riusech West Nile Virus By Frank Riusech Disease Etiology: West Nile virus(wnv), genus, flavivirus is positive- stranded RNA arbovirus (arthropod- borne), belonging to the Flaviviridae family. Included in this

More information

Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3

Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3 Original article CLINICAL EXPERIMENTAL VACCINE RESEARCH Clin Exp Vaccine Res 2016;5:26-30 pissn 2287-3651 eissn 2287-366X Comparison of the antigenic relationship between Japanese encephalitis virus genotypes

More information

Gene Vaccine Dr. Sina Soleimani

Gene Vaccine Dr. Sina Soleimani Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New

More information

Department of Microbiology, Faculty of Science, Mahidol University, Bangkok; 2

Department of Microbiology, Faculty of Science, Mahidol University, Bangkok; 2 GENETIC DIFFERENCES OF E GENE OF A THAI STRAIN OF JAPANESE ENCEPHALITIS VIRUS THAT DETERMINE SMALL PLAQUE SIZE PHENOTYPE BUT NOT NEUROVIRULENCE IN SUCKLING MICE Sasithorn Lorroengsil 1,2, Antony Chen 3,

More information

DOI: /ICJ poliovirus. [14] (Hand-Foot-Mouth Disease, HFMD) (Herpangina) 71 [26] [17,18,27] 71 picornaviridae

DOI: /ICJ poliovirus. [14] (Hand-Foot-Mouth Disease, HFMD) (Herpangina) 71 [26] [17,18,27] 71 picornaviridae 174 DOI: 10.6526/ICJ.2016.404 71 71 [14] (Hand-Foot-Mouth Disease, HFMD) (Herpangina) 71 71 picornaviridae poliovirus / 1990 71 [26] [17,18,27] 71 175 [31] ICR NOD/SCID AG129 hpsgl-1 hscarb2 (MP4) (MP4)

More information

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV 7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan

More information

Production of Interferon Alpha by Dengue Virus-infected Human Monocytes

Production of Interferon Alpha by Dengue Virus-infected Human Monocytes J. gen. Virol. (1988), 69, 445-449. Printed in Great Britain 445 Key words: IFN-ct/dengue virus/monocytes Production of Interferon Alpha by Dengue Virus-infected Human Monocytes By ICHIRO KURANE AND FRANCIS

More information

Japanese Encephalitis Virus NS1' Protein Antagonizes Interferon Beta Production

Japanese Encephalitis Virus NS1' Protein Antagonizes Interferon Beta Production Accepted Manuscript Posted Online Virologica Sinica. DOI: 10.1007/s12250-018-0067-5 Received: 27 September 2018, Accepted: 7 November 2018 RESEARCH ARTICLE Japanese Encephalitis Virus NS1' Protein Antagonizes

More information

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan International Congress Series 1263 (2004) 749 753 Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan Shin ichi Shimada a, *, Takayasu Ohtsuka b, Masayuki Tanaka b, Munehito

More information

West Nile Virus. Family: Flaviviridae

West Nile Virus. Family: Flaviviridae West Nile Virus 1 Family: Flaviviridae West Nile Virus Genus: Flavivirus Japanese Encephalitis Antigenic Complex Complex Includes: Alfuy, Cacipacore, Japanese encephalitis, koutango, Kunjin, Murray Valley

More information

III. What are the requirements for taking and passing this course?

III. What are the requirements for taking and passing this course? 1 Molecular Virology Lecture # 1: Course Introduction I. Instructor and Background Dr. Richard Kuhn rjkuhn@bragg.bio.purdue.edu B-129 Lilly Hall 494-1164 Office Hours - Wednesday 10:30-11:30 II. Objective:

More information

Case Study: West Nile Virus -Taking an Integrated National Public Health Approach to an Emerging Infectious Disease in Canada

Case Study: West Nile Virus -Taking an Integrated National Public Health Approach to an Emerging Infectious Disease in Canada 2008/SOM3/HWG/WKSP/003 Case Study: West Nile Virus -Taking an Integrated National Public Health Approach to an Emerging Infectious Disease in Canada Submitted by: Canada Health Working Group Policy Dialogue

More information

Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth

Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth Journal of General Virology (1999), 80, 1665 1671. Printed in Great Britain... Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth

More information

Fine Mapping of a cis-acting Sequence Element in Yellow Fever Virus RNA That Is Required for RNA Replication and Cyclization

Fine Mapping of a cis-acting Sequence Element in Yellow Fever Virus RNA That Is Required for RNA Replication and Cyclization JOURNAL OF VIROLOGY, Feb. 2003, p. 2265 2270 Vol. 77, No. 3 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.3.2265 2270.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Fine Mapping

More information

Long-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV)

Long-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV) Long-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV) Sutee Yoksan, M.D., Ph.D. Center for Vaccine Development, Mahidol University Joint

More information

Role of Interferon in the Propagation of MM Virus in L Cells

Role of Interferon in the Propagation of MM Virus in L Cells APPLIED MICROBIOLOGY, Oct. 1969, p. 584-588 Copyright ( 1969 American Society for Microbiology Vol. 18, No. 4 Printed in U S A. Role of Interferon in the Propagation of MM Virus in L Cells DAVID J. GIRON

More information

dengue virus DENV DENV-1 DENV-2 DENV-3 DENV-4 NS1 Non-structural protein 1 NS1 DENV antibody-dependent enhancement ADE DENV

dengue virus DENV DENV-1 DENV-2 DENV-3 DENV-4 NS1 Non-structural protein 1 NS1 DENV antibody-dependent enhancement ADE DENV 2018 9 59 17 Journal of Traditional Chinese Medicine 2018 Vol. 59 No. 17 1523 DOI 10. 13288 /j. 11-2166 /r. 2018. 17. 021 1 1 dengue virus DENV A B C 2009 WHO 1 2014 2 3 2018 DENV 1 antibody-dependent

More information

Introduction to the Impact of Resistance in Hepatitis C

Introduction to the Impact of Resistance in Hepatitis C Introduction to the Impact of Resistance in Hepatitis C Sponsored by AbbVie 2/1/2017 Presented by Sammy Saab, MD, MPH, FACG, AGAF, FAASLD February 1 st, 2017 1 AbbVie disclosures This is an Abbvie sponsored

More information

The making of Bovela - a vaccine against bovine viral diarrhea

The making of Bovela - a vaccine against bovine viral diarrhea The making of Bovela - a vaccine against bovine viral diarrhea Konrad Stadler, Boehringer Ingelheim Veterinary Research Center Manchester. January 6, 2016 Vaccines In general, a vaccine should be safe

More information

Klaus K. Orlinger, Verena M. Hoenninger, Regina M. Kofler, and Christian W. Mandl*

Klaus K. Orlinger, Verena M. Hoenninger, Regina M. Kofler, and Christian W. Mandl* JOURNAL OF VIROLOGY, Dec. 2006, p. 12197 12208 Vol. 80, No. 24 0022-538X/06/$08.00 0 doi:10.1128/jvi.01540-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Construction and Mutagenesis

More information

PREVALENCE OF WEST NILE VIRUS INFECTION IN INDIA

PREVALENCE OF WEST NILE VIRUS INFECTION IN INDIA PREVALENCE OF WEST NILE VIRUS INFECTION IN INDIA JP Thakare, TLG Rao and VS Padbidri National Institute of Virology, Pune, India Abstract. During the course of the virological investigation of cases of

More information

Received 26 September 2009/Returned for modification 29 October 2009/Accepted 18 December 2009

Received 26 September 2009/Returned for modification 29 October 2009/Accepted 18 December 2009 CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2010, p. 402 407 Vol. 17, No. 3 1556-6811/10/$12.00 doi:10.1128/cvi.00396-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Discrepancy in

More information

Flavivirus Vaccines Japanese Encephalitis and Dengue

Flavivirus Vaccines Japanese Encephalitis and Dengue Flavivirus Vaccines Japanese Encephalitis and Dengue 14 th Advanced Vaccinology Course Veyrier du Lac, France May 16, 2012 Harold S. Margolis, MD Dengue Branch Centers for Disease Control and Prevention

More information

DOI: /ICJ (Dengue fever) [2] (Aedes aegypti) (Aedes albopictus) (Dengue. (Flavivirus) 50 nm. ssrna) (capsid, C) ( ) (membrane, prm/m)

DOI: /ICJ (Dengue fever) [2] (Aedes aegypti) (Aedes albopictus) (Dengue. (Flavivirus) 50 nm. ssrna) (capsid, C) ( ) (membrane, prm/m) 210 DOI: 10.6526/ICJ.2016.504 T (Dengue fever) [1] 128 39 [2] 4 5 21,000 [3] 3 1981 1987 1995 2014 [4] 2015 ( ) (Aedes aegypti) (Aedes albopictus) (Dengue virus) (Flaviviridae) (Flavivirus) 50 nm 11 kb

More information

Dengue Infection at Children's Hospital of Bangkok

Dengue Infection at Children's Hospital of Bangkok Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,

More information

Dengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015

Dengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015 Dengue Vaccine Butantan Institute DCVMN, Bangkok, 2015 GENOME Dengue Viruses Dengue is a mosquito-borne RNA virus with 4 distinct serotypes: 1,2,3,and 4 3 structural proteins: C, prm, and E E protein is

More information

Reoviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Reoviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics Reoviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Naked icosahedral capsid (T=13), diameter 60-85 nm Capsid consists of two or three concentric protein

More information

Lecture 2: Virology. I. Background

Lecture 2: Virology. I. Background Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a

More information

Haolin Ni, 1 N. Jack Burns, 2 Gwong-Jen J. Chang, 2 Ming-Jie Zhang, 2 Mark R. Wills, 3 Dennis W. Trent, ~ Peter G. Sanders 4 and Alan D. T.

Haolin Ni, 1 N. Jack Burns, 2 Gwong-Jen J. Chang, 2 Ming-Jie Zhang, 2 Mark R. Wills, 3 Dennis W. Trent, ~ Peter G. Sanders 4 and Alan D. T. Journal of General Virology (1994), 75, 1505 1510. Printed in Great Britain 1505 Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the

More information

DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue has spread

More information

Reverse Genetics of RNA Viruses

Reverse Genetics of RNA Viruses Reverse Genetics of RNA Viruses Reverse Genetics (RG) he creation of a virus with a fulllength copy of the viral genome he most powerful tool in modern virology RG of RNA viruses Generation or recovery

More information

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v Principles of Virology Department of Molecular Genetics & Microbiology Univ ersity of Florida, Gainesv ille, FL 1 Outline Virus cultivation Assay of viruses Virus genetics 2 Virus isolation Evidence of

More information

Wen Jun Liu, Hua Bo Chen, and Alexander A. Khromykh*

Wen Jun Liu, Hua Bo Chen, and Alexander A. Khromykh* JOURNAL OF VIROLOGY, July 2003, p. 7804 7813 Vol. 77, No. 14 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.14.7804 7813.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Molecular

More information

Successful Propagation of Flavivirus Infectious cdnas by a Novel Method to Reduce the

Successful Propagation of Flavivirus Infectious cdnas by a Novel Method to Reduce the JVI Accepts, published online ahead of print on 1 January 0 J. Virol. doi:./jvi.01- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 1 Successful

More information

Temperature-Sensitive Mutants Isolated from Hamster and

Temperature-Sensitive Mutants Isolated from Hamster and JOURNAL OF VIROLOGY, Nov. 1975, p. 1332-1336 Copyright i 1975 American Society for Microbiology Vol. 16, No. 5 Printed in U.S.A. Temperature-Sensitive Mutants Isolated from Hamster and Canine Cell Lines

More information

From Mosquitos to Humans: Genetic evolution of Zika Virus

From Mosquitos to Humans: Genetic evolution of Zika Virus Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical

More information

Received 11 December 1995/Accepted 1 March 1996

Received 11 December 1995/Accepted 1 March 1996 JOURNAL OF VIROLOGY, June 1996, p. 3930 3937 Vol. 70, No. 6 0022-538X/96/$04.00 0 Copyright 1996, American Society for Microbiology Dengue Type 4 Virus Mutants Containing Deletions in the 3 Noncoding Region

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Japanese Encephalitis: Prevention Through Vaccination. Jaime A. Santos

Japanese Encephalitis: Prevention Through Vaccination. Jaime A. Santos Japanese Encephalitis: Prevention Through Vaccination Jaime A. Santos Outline Introduction: Epidemiology, Disease and Sequelae Prevention: Role of Vaccination Vaccines against JE; SP Chimeric Vaccine Conclusions

More information

The humoral immune responses to IBV proteins.

The humoral immune responses to IBV proteins. The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural

More information

Complete Nucleotide Sequence of RNA1 of Cucumber Mosaic Virus Y Strain and Evolutionary Relationships among Genome RNAs of the Virus Strains

Complete Nucleotide Sequence of RNA1 of Cucumber Mosaic Virus Y Strain and Evolutionary Relationships among Genome RNAs of the Virus Strains Complete Nucleotide Sequence of RNA1 of Cucumber Mosaic Virus Y Strain and Evolutionary Relationships among Genome RNAs of the Virus Strains Jiro KATAOKA*, Chikara MASUTA* and Yoichi TAKANAMI* Abstract

More information

Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Introduction: Materials and methods:

Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Introduction: Materials and methods: Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Haixue Zheng, Fan Yang, Ye Jin, Jianhong Guo, Jijun He, Kaiqi Lian, Zixiang Zhu, Weijun Cao, Lvlv,

More information

Sequence analysis for VP4 of enterovirus 71 isolated in Beijing during 2007 to 2008

Sequence analysis for VP4 of enterovirus 71 isolated in Beijing during 2007 to 2008 16 2009 3 4 1 Journal of Microbes and Infection, March 2009, Vol. 4, No. 1 2007 2008 71 VP4 1, 2, 2, 2, 1, 2, 2, 2, 1, 2 1., 100730; 2., 100020 : 2007 2008 71 ( EV71), 2007 3 EV71( 1, 2 ) 2008 5 EV71(

More information

Essential Role of Cyclization Sequences in Flavivirus RNA Replication

Essential Role of Cyclization Sequences in Flavivirus RNA Replication JOURNAL OF VIROLOGY, July 2001, p. 6719 6728 Vol. 75, No. 14 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.14.6719 6728.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Essential

More information

The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during p

The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during p The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during 2001 +p by Ken-Ichiro Yamada* #, Tomohiko Takasaki*, Masaru Nawa**, Reiko Nerome*, Yohko

More information

West Nile (WN) virus is a mosquito-transmitted flavivirus

West Nile (WN) virus is a mosquito-transmitted flavivirus DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus Roy A. Hall*, Debra J. Nisbet*, Kim B. Pham*, Alyssa T. Pyke, Greg A. Smith,

More information

Marmoset-based infectious disease research under biocontainment conditions

Marmoset-based infectious disease research under biocontainment conditions Marmoset-based infectious disease research under biocontainment conditions Jean Patterson, PhD Texas Biomedical Research Institute October 22 nd, 2018 West Nile virus Common marmoset found to be equivalently

More information

Persistence of West Nile Virus in the Central Nervous System and Periphery of Mice

Persistence of West Nile Virus in the Central Nervous System and Periphery of Mice Persistence of West Nile Virus in the Central Nervous System and Periphery of Mice Kim K. Appler 1, Ashley N. Brown 1,2 a, Barbara S. Stewart 1,2, Melissa J. Behr 1,2 b, Valerie L. Demarest 1, Susan J.

More information

Epidemiology and Diagnosis of West Nile Virus Infection

Epidemiology and Diagnosis of West Nile Virus Infection 21 Epidemiology and Diagnosis of West Nile Virus Infection Ikuo TAKASHIMA 1*, Hiroaki KARIWA 1 and Kazuya SHIRATO 2 1 Laboratory of Public Health, Department of Environmental Veterinary Sciences Graduate

More information

(;[rowth Charaeteristies of Influenza Virus Type C in Avian Hosts

(;[rowth Charaeteristies of Influenza Virus Type C in Avian Hosts Archives of Virology 58, 349--353 (1978) Archives of Virology by Springer-Verlag 1978 (;[rowth Charaeteristies of Influena Virus Type C in Avian Hosts Brief Report By M ~R A~N D. AUSTIn, A. S. MONTO, and

More information

Multiple transmissions of tick-borne encephalitis virus between Japan and Russia

Multiple transmissions of tick-borne encephalitis virus between Japan and Russia Genes Genet. Syst. (2007) 82, p. 187 195 Multiple transmissions of tick-borne encephalitis virus between Japan and Russia Yoshiyuki Suzuki* Center for Information Biology and DNA Data Bank of Japan, National

More information

IN VIVO STUDIES ON VIRAL VIRULENCE

IN VIVO STUDIES ON VIRAL VIRULENCE IN VIVO STUDIES ON VIRAL VIRULENCE M.Phil student: Emily TSUI Supervisor: Professor Paul K.S Chan Department of Microbiology, CUHK Date: 15th Dec, 2014 Viral Virulence Capacity of a virus to cause disease

More information

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T

More information

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses JOURNAL OF VIROLOGY, May 2011, p. 4596 4601 Vol. 85, No. 9 0022-538X/11/$12.00 doi:10.1128/jvi.00029-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Impact of Amino Acid Mutations

More information

Citation Nagasaki University ( 長崎大学 ), 博士 ( 医学 ) revised form in Epidemiology & Infe. re-sale or use in derivative works.

Citation Nagasaki University ( 長崎大学 ), 博士 ( 医学 ) revised form in Epidemiology & Infe. re-sale or use in derivative works. NAOSITE: Nagasaki University's Ac Title Author(s) Clinical, virological and epidemiol outbreak in Myanmar, 2015 Kyaw, Aung Kyaw Citation Nagasaki University ( 長崎大学 ), 博士 ( 医学 ) Issue Date 2017-09-20 URL

More information

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, TY93/H5N1 GFP-627K, or the TY93/H5N1 PB2(588-759) virus library. To establish our GFP- FACS screening platform, we compared

More information

Inhibition of Dengue Virus by Targeting Viral NS4B Protein

Inhibition of Dengue Virus by Targeting Viral NS4B Protein JOURNAL OF VIROLOGY, Nov. 2011, p. 11183 11195 Vol. 85, No. 21 0022-538X/11/$12.00 doi:10.1128/jvi.05468-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Inhibition of Dengue

More information

Acute Encephalitis in Children at Port Moresby General Hospital:

Acute Encephalitis in Children at Port Moresby General Hospital: Acute Encephalitis in Children at Port Moresby General Hospital: The role of Japanese encephalitis virus and assessing the quality of care DR K KIROMAT MMED 2017 INTRODUCTION Japanese encephalitis (JE)

More information

Relative activity (%) SC35M

Relative activity (%) SC35M a 125 Bat (H17N) b 125 A/WSN (H1N1) Relative activity (%) 0 75 50 25 Relative activity (%) 0 75 50 25 0 Pos. Neg. PA PB1 Pos. Neg. NP PA PB1 PB2 0 Pos. Neg. NP PA PB1 PB2 SC35M Bat Supplementary Figure

More information

Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia

Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia Journal of General Virology (2001), 82, 1319 1328. Printed in Great Britain... Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia Daisuke Hayasaka, 1

More information

B19, see Parvovirus B19 Bone marrow, gene transfer with parvovirus. Erythrovirus, see Parvovirus B19, Simian parvovirus

B19, see Parvovirus B19 Bone marrow, gene transfer with parvovirus. Erythrovirus, see Parvovirus B19, Simian parvovirus ... Subject Index Adeno-associated virus Cap and genome encapsidation 87 DNA integration homologous recombination 90, 91 latency vs replication 77, 78 mechanism 79 requirements 78, 79 site in human genome

More information

Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation

Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation Journal of General Virology (2006), 87, 2263 2268 DOI 10.1099/vir.0.81958-0 Short Communication Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional

More information

Seroprevalence of Yellow Fever Virus in Selected Health Facilities in Western Kenya from 2010 to 2012

Seroprevalence of Yellow Fever Virus in Selected Health Facilities in Western Kenya from 2010 to 2012 Jpn. J. Infect. Dis., 68, 230 234, 2015 Short Communication Seroprevalence of Yellow Fever Virus in Selected Health Facilities in Western Kenya from 2010 to 2012 Allan ole Kwallah 1,3,4 *, Shingo Inoue

More information

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with

More information

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus Viruses 2013, 5, 3048-3070; doi:10.3390/v5123048 Review OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against

More information

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Cell Host & Microbe, Volume 16 Supplemental Information Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Andrew Varble, Randy A. Albrecht, Simone Backes, Marshall

More information

An adapted Tembusu-like virus in chickens and geese in China

An adapted Tembusu-like virus in chickens and geese in China JCM Accepts, published online ahead of print on 12 June 2012 J. Clin. Microbiol. doi:10.1128/jcm.00655-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 An adapted Tembusu-like

More information

hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics)

hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics) Proc. Natl. Acad. Sci. USA Vol. 73, No. 6, pp. 242-246, June 976 Microbiology Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide

More information

Prevention of transfusion-transmitted arboviruses in French Polynesia

Prevention of transfusion-transmitted arboviruses in French Polynesia Prevention of transfusion-transmitted arboviruses in French Polynesia D Musso 1, V Richard 1, J Green 2,J Broult 3, M Aubry 1 1. Institut Louis Malardé, Tahiti, French Polynesia 2. Cerus Corporation, California,

More information

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Lecture 2 Biology W3310/4310 Virology Spring 2016 You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Virologists divide the infectious cycle into steps to facilitate

More information

Technology Overview. Summary

Technology Overview. Summary Live Attenuated Influenza Vaccines with Altered NS1 Technology Overview Summary Transformative Technology: Live attenuated influenza vaccines (LAIVs) with precise, genetically stable truncations of the

More information

! " ## $%& &'( ) Page 1 of 7

!  ## $%& &'( ) Page 1 of 7 ! " ## $%& &'( ) *+, -+.//0 Page 1 of 7 Introduction This report reflects the discussion and conclusions of a group of experts on regulatory aspects of vaccines from national and international regulatory

More information

Introduction. Abstract

Introduction. Abstract Comparison between Haemagglutination Inhibition (HI) Test and IgM and IgG-capture ELISA in Determination of Primary and Secondary Dengue Virus Infections Atchareeya A-nuegoonpipat a, Songthum Prakong a,

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

1. Engineering Foot-and-Mouth Disease Viruses with Improved

1. Engineering Foot-and-Mouth Disease Viruses with Improved Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Haixue Zheng, Fan Yang, Ye Jin, Jianhong Guo, Jijun He, Lvlv, Xuepeng Cai, Xiangtao Liu, Hong

More information

Rift valley fever: Next generation vaccines for an old foe

Rift valley fever: Next generation vaccines for an old foe Engineering Conferences International ECI Digital Archives Vaccine Technology IV Proceedings Spring 5-22-2012 Rift valley fever: Next generation vaccines for an old foe Brian Bird Viral Special Pathogens

More information

Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains

Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains Name: Claire Ostertag-Hill Mentor: Dr. Ling Jin Bovine herpesvirus Bovine herpesvirus-1 (BHV-1) Pathogen

More information

Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens

Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens Clin Chem Lab Med 2012;50(7):1275 1279 2012 by Walter de Gruyter Berlin Boston. DOI 10.1515/cclm-2011-0650 Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly

More information

For the control of avian influenza

For the control of avian influenza OIE Regional Expert Group Meeting for the Control of Avian influenza in Asia Sapporo, 3-5 October 2017 For the control of avian influenza Hiroshi Kida Hokkaido University Research Center for Zoonosis Control

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.

More information